Kimberly P. Dunsmore

Hematology | Oncology

500 Ray C Hunt Dr
Charlottesville, VA 22903

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology Group.

Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology Group.

Journal: Blood advances

Published: January 26, 2026

Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 06, 2026

Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Journal: Blood cancer discovery

Published: December 04, 2025

Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.

Journal: Blood cancer discovery

Published: January 29, 2025

STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL.

STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL.

Journal: Blood

Published: January 27, 2025

Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes.

Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes.

Journal: Research square

Published: August 26, 2024

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.

Journal: Leukemia

Published: May 07, 2024

A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.

A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.

Journal: Nature cancer

Published: February 19, 2024

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.

Journal: Research square

Published: November 14, 2023

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.

Journal: Nature

Published: October 24, 2023

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.

Journal: Blood

Published: September 14, 2023

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.

Journal: Blood

Published: April 07, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026